Page 4 - Compass Pathways News Today

Could investing in "magic" mushrooms make you money? These promising medical developments might see you embark on the trip of a lifetime.

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) shares were up 5.3% on Tuesday . The company traded as high as $11.25 and last traded at $11.07. Approximately 446,463 shares were traded during trading, a decline of 32% from the average daily volume of 657,411 shares. The stock had previously closed at $10.51. Wall Street […]

COMPASS Pathways (NASDAQ:CMPS – Get Free Report) is scheduled to post its quarterly earnings results on Friday, February 23rd. COMPASS Pathways Stock Down 2.5 % Shares of NASDAQ CMPS opened at $9.92 on Thursday. COMPASS Pathways has a one year low of $5.01 and a one year high of $12.30. The stock has a market […]

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) traded up 5.3% during trading on Tuesday . The stock traded as high as $11.25 and last traded at $11.07. 446,463 shares traded hands during trading, a decline of 32% from the average session volume of 657,411 shares. The stock had previously closed at $10.51. Wall Street […]

The lofty target is closer to being within reach than it may seem at first.

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression. Another 18.1% live with anxiety disorders. ...

About 43.8 million adults in the U.S. experience a mental health issue in a given year, according to the National Institute of Mental Health (NAMI). Nearly 16 million of those adults live with major depression. Another 18.1% live with anxiety disorders. ...

Mind-altering substances could be on the cusp of medical acceptability, with sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing their potential

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...

At the moment, about 14 million people live with PTSD just in the U.S. Unfortunately, despite extensive clinical research, PTSD is still a significant unmet medical need. However, that may soon change with the US FDA’s acceptance of a New Drug ...